TD Waterhouse Canada’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Sell
1,668
-40
-2% -$6.88K ﹤0.01% 971
2026
Q1
$290K Sell
1,708
-21,972
-93% -$3.76M ﹤0.01% 954
2025
Q4
$4M Buy
23,680
+22,182
+1,481% +$3.6M 0.02% 327
2025
Q3
$223K Sell
1,498
-553
-27% -$75.5K ﹤0.01% 857
2025
Q2
$262K Sell
2,051
-600
-23% -$73.7K ﹤0.01% 774
2025
Q1
$329K Sell
2,651
-3,164
-54% -$429K ﹤0.01% 718
2024
Q4
$769K Sell
5,815
-6,553
-53% -$921K 0.01% 552
2024
Q3
$1.79M Buy
12,368
+486
+4% +$70.3K 0.01% 408
2024
Q2
$1.63M Buy
11,882
+7,244
+156% +$967K 0.01% 407
2024
Q1
$650K Buy
4,638
+2,384
+106% +$326K ﹤0.01% 568
2023
Q4
$338K Sell
2,254
-707
-24% -$86.3K ﹤0.01% 598
2023
Q3
$387K Buy
2,961
+830
+39% +$106K ﹤0.01% 554
2023
Q2
$279K Sell
2,131
-119
-5% -$15.5K ﹤0.01% 618
2023
Q1
$305K Sell
2,250
-658
-23% -$86.1K ﹤0.01% 598
2022
Q4
$391K Buy
2,908
+463
+19% +$59.8K ﹤0.01% 560
2022
Q3
$303K Sell
2,445
-12,391
-84% -$1.54M ﹤0.01% 594
2022
Q2
$2.09M Buy
14,836
+13,124
+767% +$1.56M 0.02% 311
2022
Q1
$245K Buy
1,712
+36
+2% +$4.69K ﹤0.01% 689
2021
Q4
$267K Buy
+1,676
New +$259K ﹤0.01% 710

Other funds holding IBB

TD Waterhouse Canada's IBB Position: Q2 2026 in Review

TD Waterhouse Canada reduced its iShares Biotechnology ETF (IBB) stake by 2.3% in Q2 2026, selling an estimated $6.88K and leaving 1,668 shares worth $317K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

TD Waterhouse Canada first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $4M in Q4 2025. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • TD Waterhouse Canada held 1,668 shares of iShares Biotechnology ETF worth $317K as of Q2 2026.
  • TD Waterhouse Canada sold 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
  • iShares Biotechnology ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #971 holding.
  • TD Waterhouse Canada first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • TD Waterhouse Canada's iShares Biotechnology ETF position peaked at $4M in Q4 2025.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.